Therapeutic monoclonal antibodies for respiratory diseases: Current challenges and perspectives, March 31 – April 1, 2016, Tours, France

Monoclonal antibody (mAb) therapeutics have tremendous potential to benefit patients with lung diseases, for which there remains substantial unmet medical need. To capture the current state of mAb research and development in the area of respiratory diseases, the Research Center of Respiratory Diseas...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:MAbs
Hauptverfasser: Desoubeaux, Guillaume, Reichert, Janice M., Sleeman, Matthew, Reckamp, Karen L., Ryffel, Bernhard, Adamczewski, Jörg P., Sweeney, Theresa D., Vanbever, Rita, Diot, Patrice, Owen, Caroline A., Page, Clive, Lerondel, Stéphanie, Le Pape, Alain, Heuze-Vourc'h, Nathalie
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2016
Schlagworte:
Meeting Report
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4968091/
https://ncbi.nlm.nih.gov/pubmed/27266390
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/19420862.2016.1196521
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge